| scholarly article | Q13442814 |
| P356 | DOI | 10.1136/THX.50.5.543 |
| P953 | full work available at URL | https://thorax.bmj.com/content/thoraxjnl/50/5/543.full.pdf |
| https://europepmc.org/articles/PMC1021226 | ||
| https://europepmc.org/articles/PMC1021226?pdf=render | ||
| https://syndication.highwire.org/content/doi/10.1136/thx.50.5.543 | ||
| P932 | PMC publication ID | 1021226 |
| P698 | PubMed publication ID | 7597669 |
| P5875 | ResearchGate publication ID | 15600810 |
| P2093 | author name string | R. van Furth | |
| P. J. van den Broek | |||
| R. Bohte | |||
| P2860 | cites work | Epidemiology of community-acquired respiratory tract infections in adults. Incidence, etiology, and impact | Q34198867 |
| Community-acquired pneumonia requiring hospitalization: 5-year prospective study | Q34542314 | ||
| Antigen detection in pneumococcal pneumonia | Q36832511 | ||
| Chlamydia pneumoniae infections in Norway 1981-87 earlier diagnosed as ornithosis | Q37895606 | ||
| New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases | Q37896178 | ||
| Is Chlamydia TWAR of significance in The Netherlands? | Q37896448 | ||
| Etiology of community-acquired pneumonia in patients requiring hospitalization | Q37904275 | ||
| Comparative clinical and laboratory features of legionella with pneumococcal and mycoplasma pneumonias | Q40797945 | ||
| Role of pneumococcal antigen in the diagnosis of pneumococcal pneumonia | Q41146091 | ||
| Invasive Haemophilus influenzae disease in adults. A prospective, population-based surveillance. CDC Meningitis Surveillance Group | Q44145215 | ||
| Proportionate mortality trends: 1950 through 1986 | Q68445797 | ||
| Community-acquired pneumonia | Q69393922 | ||
| Community-acquired pneumonia | Q72077200 | ||
| Invasive Haemophilus influenzae disease in adults | Q74301652 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pneumonia | Q12192 |
| P304 | page(s) | 543-547 | |
| P577 | publication date | 1995-05-01 | |
| P1433 | published in | Thorax | Q7796158 |
| P1476 | title | Aetiology of community-acquired pneumonia: a prospective study among adults requiring admission to hospital | |
| P478 | volume | 50 |
| Q37859065 | Aetiological diagnosis of community acquired pneumonia: utility of rapid microbiological methods with respect to disease severity |
| Q54139422 | Aetiology and risk factors of community-acquired pneumonia in hospitalized patients in Norway. |
| Q37721755 | Are third-generation cephalosporins unavoidable for empirical therapy of community-acquired pneumonia in adult patients who require ICU admission? A retrospective study |
| Q44919640 | Atypical pneumonia--time to breathe new life into a useful term? |
| Q24675547 | BTS Guidelines for the Management of Community Acquired Pneumonia in Adults |
| Q44707933 | Bacterial pneumonia following cytotoxic chemotherapy for lung cancer: clinical features, treatment outcome and prognostic factors |
| Q34472366 | Characterization of the extent of a large outbreak of Legionnaires' disease by serological assays |
| Q37881509 | Chlamydia DNA extraction for use in PCR: stability and sensitivity in detection |
| Q37863465 | Chlamydia pneumoniae and Mycoplasma pneumoniae pneumonia: comparison of clinical, epidemiological characteristics and laboratory profiles |
| Q33362080 | Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever |
| Q54502739 | Clinical features predicting failure of pathogen identification in patients with community acquired pneumonia. |
| Q44192579 | Community acquired pneumonia CAP |
| Q36501395 | Community acquired pneumonia: aetiology and usefulness of severity criteria on admission |
| Q42637472 | Community-acquired lung abscess caused by Legionella micdadei in a myeloma patient receiving thalidomide treatment |
| Q77464123 | Community-acquired pneumonia |
| Q77434756 | Community-acquired pneumonia: epidemiology, etiology, treatment |
| Q35922138 | Comparison and evaluation of real-time PCR, real-time nucleic acid sequence-based amplification, conventional PCR, and serology for diagnosis of Mycoplasma pneumoniae |
| Q39732930 | Detection and treatment of bloodstream infection: laboratory reporting and antimicrobial management |
| Q36747517 | Development and evaluation of a novel multiplex PCR technology for molecular differential detection of bacterial respiratory disease pathogens |
| Q35984518 | Diagnosis of Legionella infection in Legionnaires' disease |
| Q44160564 | Diagnostic methods and treatment of community-acquired pneumonia in Spain: NACE study |
| Q33749681 | Diagnostic testing for community-acquired pneumonia |
| Q37860802 | Diagnostic tests for agents of community-acquired pneumonia |
| Q71347422 | Early recognition of Streptococcus pneumoniae in patients with community-acquired pneumonia |
| Q47711077 | Effectiveness of a 23-valent polysaccharide vaccine in preventing pneumonia and non-invasive pneumococcal infection in elderly people: a large-scale retrospective cohort study. |
| Q42208977 | Effects of holding time and measurement error on culturing Legionella in environmental water samples |
| Q37896600 | Elderly patients with community-acquired pneumonia: optimal treatment strategies |
| Q35957889 | Epidemiology and etiology of community-acquired pneumonia |
| Q33848059 | Epidemiology of pneumococcal infections in the elderly |
| Q39439981 | Erythromycin inhibits tumor necrosis factor alpha and interleukin 6 production induced by heat-killed Streptococcus pneumoniae in whole blood |
| Q44059050 | Evolving Understanding of the Causes of Pneumonia in Adults, With Special Attention to the Role of Pneumococcus. |
| Q57230910 | Geographical variation of sporadic Legionnaires' disease analysed in a grid model |
| Q28249185 | Guidelines for the management of adult lower respiratory tract infections--full version |
| Q28075109 | Impact of pneumococcal conjugate vaccination: a retrospective study of hospitalization for pneumonia in North-East Italy |
| Q34030766 | Importance of atypical pathogens of community-acquired pneumonia |
| Q47766508 | Improved diagnosis of the etiology of community-acquired pneumonia with real-time polymerase chain reaction |
| Q51102847 | Incidence and completeness of notification of Legionnaires' disease in The Netherlands: covariate capture-recapture analysis acknowledging regional differences. |
| Q37270551 | Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP: results from the German competence network CAPNETZ. |
| Q84978360 | Legionella pneumophila monoclonal antibody subgroups and DNA sequence types isolated in Canada between 1981 and 2009: Laboratory Component of National Surveillance |
| Q48617303 | Legionnaires disease with bacteremic coinfection |
| Q38437227 | Mechanisms and impact of genetic recombination in the evolution of Streptococcus pneumoniae |
| Q33971723 | Molecular detection of Mycoplasma pneumoniae in adults with community-acquired pneumonia requiring hospitalization |
| Q42779179 | New outbreak of legionnaires' disease in the United Kingdom |
| Q37043541 | Outbreak of Pneumococcal Pneumonia among Military Recruits |
| Q34224648 | Pathogens involved in lower respiratory tract infections in general practice |
| Q37881460 | Pneumococcal community-acquired pneumonia in 148 hospitalized adult patients |
| Q34021594 | Pneumococcal pneumonia: differences according to blood culture results. |
| Q34745681 | Pneumonia as the most common lower respiratory tract infection |
| Q41700909 | Practical considerations and guidelines for the management of community-acquired pneumonia |
| Q37354784 | Predictive factors of true bacteremia and the clinical utility of blood cultures as a prognostic tool in patients with community-onset pneumonia |
| Q34118967 | Pulmonary exacerbations in cystic fibrosis with negative bacterial cultures |
| Q43650693 | Rapid diagnosis of Mycoplasma pneumoniae by polymerase chain reaction in community-acquired lower respiratory tract infections |
| Q41451327 | Role of oral antibiotics in treatment of community-acquired lower respiratory tract infections |
| Q64133453 | Sparfloxacin versus clarithromycin in the treatment of community-acquired pneumonia |
| Q37374826 | Streptococcus pneumoniae DNA load in blood as a marker of infection in patients with community-acquired pneumonia |
| Q40662713 | Summary of Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Disease Society and the Canadian Thoracic Society |
| Q39551907 | The incidence of Legionella pneumophila: a prospective study in a tertiary care hospital in India |
| Q38067619 | The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis. |
| Q44993851 | Update to the Latin American Thoracic Society (ALAT) Recommendations on Community-Acquired Pneumonia |
| Q81761042 | Value of intensive diagnostic microbiological investigation in low- and high-risk patients with community-acquired pneumonia |
| Q37878319 | Value of the polymerase chain reaction assay in noninvasive respiratory samples for diagnosis of community-acquired pneumonia. |
| Q37734448 | Viral and bacterial interactions in pneumonia. |
| Q78352512 | [Cost-effectiveness of 23-valent antipneumococcical vaccination in Catalonia (Spain)] |
| Q79340135 | [Managing lower respiratory tract infections in immunocompetent patients. Definitions, epidemiology, and diagnostic features] |
Search more.